Here we report a significant reduction in native NET function and surface expression in these cells following phorbol ester (␤-PMA) treatment. The ␤-PMA-mediated down-regulation of NET occurs by a rapid sequestration of NETs from the plasma membrane and is calciumindependent. Reversible biotinylation experiments revealed a significant enhancement of NET endocytosis following ␤-PMA treatment. Chemical treatments and expression of dominant negative mutants of dynamin 1 and 2 failed to prevent the ␤-PMA effect, suggesting a clathrin-independent pathway. In contrast, treatment with the cholesterol-disrupting agent filipin, which blocks caveolae/lipid raft-mediated internalization, completely blocked the ␤-PMA-mediated NET sequestration. Discontinuous sucrose density gradient centrifugation revealed NET in the lipid raft fractions. Following ␤-PMA treatment, there was reduced NET levels in the lipid raft fractions suggesting that cholesterol-rich lipid rafts mediate PKC-triggered NET internalization. Metabolic labeling and immunoprecipitation studies revealed that NET phosphorylation is stimulated severalfold by PKC activation and protein phosphatase 1/2A inhibition. Together, these findings demonstrate for the first time that in trophoblasts (i) PKC activation regulates NET function and surface expression by an enhanced internalization process that is lipid raft-mediated and (ii) PKC and protein phosphatase(s) modulation regulates NET phosphorylation.
NET, 1 which belongs to GAT1/NET family of Na ϩ /Cl Ϫ -dependent transporters, is selectively expressed on noradrenergic nerve terminals and exerts spatial and temporal control over the actions of NE (1, 2) . NET is also an important target for various antidepressants and psychostimulants (3) . Functional silencing of NET through genetic manipulations results in altered behavior when animals are stressed or challenged pharmacologically (hypersensitivity to psychostimulants and opiates) (4, 5) . NE uptake sites and NET activity are also compromised in cardiovascular diseases and brain disorders (6 -8) . A point mutation in NET (A457P in exon 9 of the NET gene) has been shown to be associated with orthostatic intolerance (9) , whereas another study shows the absence of this specific mutation in all the orthostatic intolerance patients examined (10) . The A457P mutation disrupts surface expression of mutant and wild type NETs when coexpressed in Chinese hamster ovary cells (11) .
Diverse stimuli, including neuronal activity, peptide hormones, and second messengers elevated after receptor activation, regulate NET. For example, activation of PKC downregulates the activity of NET and results in redistribution of NET from the plasma membrane (12, 13) . Activation of PKC leads to a reduction in amine transport capacity, revealed by a change in maximal transport with little or no change in substrate affinity (12) (13) (14) . Similarly, inhibition of protein phosphatase 1/2A (PP1/PP2A) reduces amine transport activity, and stimulates transporter phosphorylation (15) . PP2Ac exists in physical complexes containing biogenic amine transporters including NET (16) . NET bears multiple consensus sites for PKC phosphorylation on putative cytoplasmic domains (3) . Determinants within the C-terminal region of NET dictate NET trafficking, stability, and activity (17) . Although membrane trafficking is implicated in PKC-mediated regulation of NET proteins, it is not yet known whether NET cell surface losses are due to increased internalization (endocytosis) or decreased recycling. It is also not known whether NET undergoes regulated phosphorylation.
Although dynamin-dependent clathrin-mediated internalization is involved in the regulation of DAT and GAT1 trafficking (18 -20) , such a mechanism is not known for NET. Certain endocytic pathways utilize glycosylphosphatidylinositol-anchored membrane proteins (lipid rafts) and caveolae to concentrate and internalize molecules such as folate (21) . The associ-ation of multiple signaling molecules with caveolae and lipid rafts suggests their role in coordinating signal transductions with internalization of molecules (22) .
Human placenta expresses both SERT and NET (23) (24) (25) , and we have recently developed trophoblast cultures from the rat placenta that robustly express endogenous NET (26) . In this study, we tested the hypothesis that the ␤-PMA-induced downregulation of NET in trophoblasts occurs by an enhanced internalization process and that this internalization is dynamindependent. Our results demonstrate that in trophoblasts, PKC activation enhances NET internalization and that the internalization occurs in a calcium-and clathrin (dynamin)-independent manner. Surprisingly, cholesterol-disrupting agents prevented the ␤-PMA-induced NET internalization. In addition, we show that NET protein is present in lipid raft fractions and demonstrate that NETs internalize via lipid rafts following ␤-PMA treatment. Finally we provide evidence that PKC and PP1/PP2A regulate the phosphorylation of native NETs. These findings suggest that NET function in the trophoblast is regulated by endogenous kinases and phosphatases, and the regulation of NET may play a role in placental control of amine entry or exit in order to cope with the fetal demands, such as fetal growth, and the maternal insults, such as drug abuse by the pregnant mother.
EXPERIMENTAL PROCEDURES

Materials
␤-and ␣-PMA were from Alexis Biochemicals (San Diego, CA). Rat NET polyclonal antibody was raised against the peptide WERVAYGIT-PENEHHLVAQRDVR, amino acids 535-557 of rNET supplied by the commercial vendor, Invitrogen. Mouse monoclonal antibodies to dynamin 1, dynamin 2, caveolin 1, and PKC␣ were from BD Biosciences. Mouse monoclonal antibody to PKC⑀ was from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal anti-HA antibody was from Roche Applied Science. Polyclonal anti-GFP and anti-Myc antibodies were from Clontech (Palo Alto, CA). Mouse anti-TfR antibody was from Zymed Laboratories Inc. (South San Francisco, CA). All other chemicals were from Sigma unless otherwise noted.
Rat Placental Trophoblast Cultures
Placentas were isolated from pregnant rats at gestation day 17, and trophoblasts were isolated as described earlier (26) . All animal procedures were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Placental tissue was minced and digested with 0.1% w/v collagenase plus 0.002% w/v DNase in 10 ml of M199 medium containing Hanks' salts. Tissue was dispersed in 1ϫ Ca 2ϩ -and Mg 2ϩ -free Hanks' balanced salt solution containing 0.1% BSA followed by filtration through 4 layers of 150-m nylon cloth. Trophoblasts were isolated by discontinuous Percoll gradient (Pharmacia Fine Chemicals, Piscataway, NJ) (10 -70%) centrifugation and cultured in a mixture of Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM L-glutamine and penicillin (100 units/ml), and streptomycin (100 g/ml). Cells seeded in 24-well cell culture plates (100,000 cells/well) or 35-mm dishes or 6-well plates (500,000 cells/dish or well) were allowed to grow in an atmosphere of 95% air, 5% CO 2 and used for the experiments.
Immunostaining
Trophoblasts grown on glass coverslips were fixed in 4% paraformaldehyde (Electron Microscopy Sciences, Ft. Washington, PA) in PBS/ Ca-Mg (phosphate-buffered saline with 0.5 mM CaCl 2 and 1 mM MgCl 2 ) for 15 min at room temperature (RT), rinsed with PBS/Ca-Mg, and quenched with 50 mM NH 4 Cl in PBS/Ca-Mg. The cells were permeabilized with 0.1% Triton X-100 in PBS for 15 min at RT and blocked with 2% BSA in 0.1% Triton X-100 in PBS/Ca-Mg. Trophoblasts were incubated with the primary antibody (polyclonal anti-rNET, raised against rNET sequence (WERVAYGITPENEHHLVAQRDVR) in PBS containing 0.1% Triton X-100 and 2% BSA for 1 h at RT. After washing the cells three times with PBS/Ca-Mg, 1:1000 dilution of the secondary antibody (Cy3-conjugated donkey anti-rabbit IgG, Jackson ImmunoResearch Laboratories Inc, West Grove, PA) in PBS containing 0.1% Triton X-100 and 2% BSA was added and incubated for 1 h at RT. The cells were washed as before with PBS, mounted on glass slides in Aqua-Poly/ Mount (Polysciences, Inc., Warrington, PA), and examined using a Zeiss Axiovert 135 confocal microscope.
Treatments and NE Uptake Assays
Trophoblasts were treated with the vehicle or ␤-PMA (0.5 M) for 30 min at 37°C. Other treatments with various reagents were performed as described in appropriate places. Uptake measurements were performed by incubating the trophoblasts for 10 min at 37°C, with , a specific radioligand for NET, was measured using both intact trophoblasts and isolated membrane fractions. Trophoblasts were treated with the vehicle or ␤-PMA as described under "Treatments and NE Uptake Assays," washed with ice-cold binding buffer (10 mM Na 2 HPO 4 , 120 mM NaCl and 5 mM KCl, pH 7.4 containing 0.32 M sucrose), and incubated with increasing concentrations (0.1-5 nM) of [ 3 H]nisoxetine in binding buffer on ice for 2 h (saturates by 2 h). At the end of the incubations, the cells were washed, lysed, and measured for radioactivity.
For [ 3 H]nisoxetine binding in membranes, trophoblast cultures in 35-mm dishes were treated with the vehicle or ␤-PMA as described under uptake assays, and the cells were collected in ice-cold phosphatebuffered saline (PBS). Pelleted cells were resuspended in ice-cold binding buffer (10 mM Na 2 HPO 4 , 120 mM NaCl, and 5 mM KCl, pH 7.4) containing a mixture of protease inhibitors (1 g/ml each of aprotinin, leupeptin, and soybean trypsin inhibitor, 1 M each of pepstatin and iodoacetamide, 250 M phenylmethylsulfonyl fluoride) and centrifuged at 20,000 ϫ g. The resulting pellet was homogenized in 4 ml of binding buffer with a Polytron (Brinkmann Instruments) at 25,000 rpm for 5 s, and the homogenate was centrifuged at 20,000 ϫ g for 30 min. The resulting pellet (membrane fraction) was resuspended in ice-cold binding buffer, and membrane protein was estimated by the Bradford method (Bio-Rad). Membranes (50 g of protein) were incubated with increasing concentrations (0.1-5 nM) of [ 3 H]nisoxetine for 2 h (saturates by 2 h) at 4°C and collected (Brandel, Gaithersburg, MD) on GF/B glass filters (Whatman, Clifton, NJ) presoaked in 0.3% polyethyleneimine. Filters were washed, and bound radioactivity was measured by liquid scintillation counting. Nonspecific binding, defined as the binding in the presence of 10 M DS, was subtracted from total binding to obtain specific binding to whole cells as well as to membranes. Scatchard analysis was used to estimate ligand K d and binding site density (B max ).
Surface Biotinylation-Although nisoxetine has been used as a NET ligand for binding studies to quantify cell surface NET density (12, 27) , nisoxetine may enter the cell even at 4°C. Cell surface biotinylation and immunoblot analyses were employed (28) to quantify more accurately the amount of NET protein distributed between cell surface and intracellular pools. Trophoblasts subjected to various treatments were washed and incubated with the cell membrane-impermeable reagent, sulfo-NHS-biotin (1.5 mg/ml, Pierce) for 1 h at 4°C in PBS/Ca-Mg (138 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 9.6 mM Na 2 HPO 4 , 1 mM MgCl 2 , 0.1 mM CaCl 2 , pH 7.3). The biotinylating agent was removed by incubating twice with 100 mM glycine for 30 min. Cells were washed with PBS/Ca-Mg and lysed at 4°C with 400 l of RIPA buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate) containing protease inhibitors. Lysates were centrifuged at 20,000 ϫ g for 30 min at 4°C, and the supernatants were incubated with monomeric avidin beads for 1 h at room temperature. The beads were washed three times with RIPA buffer, and adsorbed proteins were eluted in 50 l of Laemmli buffer (62.5 mM Tris-HCl, pH 6.8, 20% glycerol, 2% SDS, 5% ␤-mercaptoethanol, and 0.01% bromphenol blue). An aliquot (40 l) of total cell lysate from each sample and all (50 l) of the avidin-bound samples were analyzed by immunoblotting with NET-specific antibody. To visualize intracellular NET, proteins from unbound fractions were precipitated with trichloroacetic acid, and equal amounts of protein were analyzed by immunoblotting with NET antibody. To validate the surface localization of biotinylated NET protein, blots were stripped and reprobed with anticalnexin antibody (1:1000, Stressgen Biotechnologies, Victoria, British Columbia, Canada). Band intensities were quantified using NIH Image (version 1.62). Exposures were precalibrated to ensure quantitation within the linear range of the film, and multiple exposures were taken to validate linearity of quantitation. Values of total, nonbiotinylated, and surface NET proteins were normalized using levels of calnexin immunoreactivity in total cell extract, and values were averaged across three experiments.
Calcium Depletion
In one set, trophoblasts were treated with the membrane-permeant Ca 2ϩ chelator BAPTA-AM (10 M) in Ca 2ϩ -free KRH buffer for 2 h at 37°C to deplete both external and internal Ca 2ϩ (29) . After BAPTA-AM treatment, ␤-PMA (0.5 M final concentration) or the vehicle was added, and cells were incubated at 37°C for 30 min in the continued presence of BAPTA-AM. In another set, trophoblasts were incubated at 37°C with 0.001% dimethyl sulfoxide (Me 2 SO) (vehicle for BAPTA-AM) in Ca 2ϩ (2.2 mM) containing KRH buffer for 2 h. After the treatment, ␤-PMA (0.5 M final concentration) or the vehicle was added, and cells were incubated at 37°C for another 30 min. Following treatments, uptake assays and biotinylation experiments were performed as described above.
Reversible Biotinylation (Internalization Assay)
Reversible biotinylation was performed as described (30) . Trophoblasts were cooled rapidly to 4°C to inhibit endocytosis by washing with cold PBS and surface-biotinylated with a disulfide-cleavable biotin (sulfo-NHS-SS-biotin; Pierce), and free biotinylating reagent was removed by quenching with glycine. NET endocytosis was initiated by incubating the cells with prewarmed media containing ␤-PMA or the vehicle for indicated times at 37°C. At the end of each time point, the reagents were removed, and fresh pre-chilled media were added to stop the endocytosis. The cells were then washed and incubated twice with 250 M sodium 2-mercaptoethanesulfonate (MesNa), a reducing agent in PBS/Ca-Mg for 20 min to dissociate the biotin from cell surfaceresident proteins via disulfide exchange. To define total biotinylated NETs, one dish of biotinylated trophoblasts was not subjected to reduction with MesNa and directly processed for extraction followed by isolation by avidin beads. To define MesNa-accessible NETs, another dish of cells was treated with MesNa immediately (at 0 time) following biotinylation at 4°C to reveal the quantity of surface NET biotinylation that MesNa can reverse efficiently.
At the end of the treatments, trophoblasts were solubilized in RIPA, and biotinylated NETs were separated from nonbiotinylated proteins by using monomeric avidin beads. Biotinylated proteins were eluted from beads and resolved by SDS-PAGE. NET proteins in the fractions were visualized with NET-specific antibody as described under "Surface Biotinylation." NET bands were scanned, and the band densities were quantified by NIH Image 1.62 software (National Institutes of Health).
Manipulations (Chemical Treatments) to Block NET Internalization
Trophoblasts were subjected to various conditions that inhibit endocytosis mediated by either dynamin (clathrin-coated pits) (30) or caveolae/lipid rafts (31, 32) . Trophoblasts were incubated with cycloheximide (30 g/ml) for 30 min prior to treatment with ␤-PMA to prevent the confounding effects of protein synthesis (18) . Procedures to inhibit endocytosis were also performed for 30 min prior to experimentation coincident with cycloheximide treatment. The reagents and conditions to block clathrin-mediated endocytosis are as follows: (i) Control buffer, KRH buffer; (ii) K ϩ depletion, trophoblasts were incubated at 37°C for 5 min in hypotonic shock solution (serum-free DMEM and distilled water in 1:1 ratio) and then rinsed and incubated with K ϩ depletion buffer (50 mM HEPES; 100 mM NaCl, pH 7.4; 1 mM CaCl 2 ; 1 mM MgCl 2 ); (iii) Hypertonic medium, 0.5 M sucrose in KRH buffer; (iv) chemical inhibition by (a) concanavalin A (ConA) (250 g/ml) and (b) monodansyl cadaverine (MDC) (50 M). The reagents and conditions to block caveolae/lipid raft-mediated endocytosis are as follows: (i) filipin (5 g/ml) and (ii) nystatin (5 g/ml) in KRH assay buffer. Treatments with appropriate vehicles were carried out for controls. Following the treatments, trophoblasts were treated with vehicle or ␤-PMA as described before and used for NE uptake measurement and biotinylation studies as described above. Because trophoblasts also express Na ϩ /Cl Ϫ -dependent taurine transporters, and PKC activation down-regulates the taurine transporter, 2 the effect of these manipulations on ␤-PMA-mediated inhibition of taurine transport was examined. In addition, following filipin treatment, ␤-PMA induced translocation of PKC isoforms (␣ and ⑀) was measured as described by Karl and Divald (33) to determine whether PKC signaling pathways remain intact in response to cholesterol-depleting agents.
K44A Dominant Negative Dynamin and Caveolin Mutant Expression
Trophoblasts were tested for the endogenous expression of dynamin 1, dynamin 2, and caveolin 1 by immunoblotting with monoclonal antibodies to dynamin 1, dynamin 2, and caveolin 1, respectively. Trophoblasts were transiently transfected with K44A mutant cDNAs of dynamin 1 (HA-tagged) (34) or dynamin 2 (GFP-tagged) (35) , or Myc-tagged S80E mutant cDNA of caveolin 1 (36), or HA-tagged DGV mutant cDNA of caveolin 3 (32), or empty vectors (control) using FuGENE 6 Transfection Reagent (Roche Applied Bioscience), and cultures were maintained for 48 h prior to experimentation (0.25 g/well in 24-well plates or 1 g/well in 6-well plates). Cells grown in 24-well plates were used for NE uptake measurements, and cells grown in 6-well plates were used for biotinylation experiments to assess the ability of these mutants to block ␤-PMA-mediated NET endocytosis. To determine whether dominant negative dynamin mutants impaired clathrin-mediated endocytosis, TfR internalization was assessed by surface biotinylation experiments using trophoblasts transfected with vector alone or K44A dynamin 1 mutant. To determine whether dominant negative mutants of caveolin impaired caveolin-dependent endocytosis, cholera toxin B (CTXB) internalization was assessed. Trophoblasts transfected with vector alone, S80E caveolin 1, or DGV caveolin 3 were incubated at 4°C with horseradish peroxidase-conjugated CTXB (4 g/ml PBS/Ca-Mg) for 45 min. Unbound CTXB was removed by washing with cold PBS/Ca-Mg. Internalization of bound CTXB was carried out by incubating the cells in PBS/Ca-Mg at 37°C for 2.5 h. Following the incubation, biotinylation experiments were performed on the trophoblasts as described under "Surface Biotinylation." Equal amounts (150 g) of protein from total lysates, all (50 l) of the avidin-bound samples, and equal amounts (300 l concentrated to 150 l) of unbound fractions were dotted on a nitrocellulose membrane and developed with ECL reagents (37) . Dot blots were scanned, and the dot densities were quantified by NIH Image 1.62 software (National Institutes of Health).
Lipid Raft Isolation
Lipid rafts were isolated from vehicle or ␤-PMA-treated trophoblasts using the protocol described earlier (38) with few modifications. Trophoblasts were lysed in 1.5 ml of MBS (25 mM MES and 150 mM NaCl, pH 6.5) containing 1% Triton X-100 and a mixture of protease inhibitors (1 M pepstatin A, 250 M phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 g/ml aprotinin) by using Dounce homogenizer with 10 up and down strokes at 4°C. Equal volumes of 80% (w/v) sucrose in MBS were added to the homogenates. Cell lysates in 40% sucrose were placed at the bottom of SW41 centrifuge tubes and overlaid successively with 4 ml of 30% sucrose and 3 ml of 5% sucrose. The tubes were centrifuged at 188,000 ϫ g for 18 h at 4°C, and 1-ml fractions were collected from the top. The pellets were resuspended in 1 ml of MBS by passing through 27 1 ⁄2-gauge needle. Proteins from collected fractions were trichloroacetic acid-precipitated, washed in ether, air-dried, and subjected to 4 -15% linear gradient SDS-PAGE. After transfer to polyvinylidene difluoride membrane, the presence of NET and other proteins was visualized by immunoblotting with specific antibodies.
Metabolic Labeling and Immunoprecipitation (Phosphorylation Assay)
Trophoblasts were incubated at 37°C in phosphate-free DMEM for 1 h and then with 1 mCi/ml of carrier-free [ 32 P] orthophosphate (Am-ersham Biosciences) for 2 h (39). ␤-PMA (0.5 M) or okadaic acid (10 nM) or vehicle was added to the medium, and the incubation was continued at 37°C for 30 min. Cells were washed with cold PBS and lysed in 400 l of RIPA buffer containing protease inhibitors and phosphatase inhibitors (10 mM NaF, 50 mM sodium pyrophosphate, 1 mM sodium orthovanadate, and 1 M of okadaic acid). Extracts were centrifuged at 20,000 ϫ g for 30 min at 4°C, and the supernatants were precleared using 100 l of Protein A-Sepharose beads (39) . NET protein was immunoprecipitated overnight at 4°C by the addition of NET-specific antibody on end-over-end continuous mixing, followed by a 1-h incubation with Protein A-Sepharose beads (3 mg in 100 l in RIPA buffer) at 22°C (room temperature). The immunoadsorbents were washed with ice-cold RIPA buffer, extracted with 50 l of Laemmli, and resolved by SDS-PAGE (10%). The radiolabeled proteins were detected by autoradiography, and digitized autoradiograms were evaluated on multiple film exposures to ensure quantitation within the linear range of film exposure.
Statistical Analyses
Statistical significance for NE uptake values and band densities were calculated using Student's t test, and comparisons were made between two groups (each treatment compared with respective vehicle control).
RESULTS
Endogenous NET Expression in Rat Placental
Trophoblasts-Recently, we have successfully developed a primary cell culture model system of rat placental trophoblasts (Fig. 1A) to study NET function in a native cell environment. By using this native system, we demonstrated that rat trophoblasts exhibit Na ϩ and Cl Ϫ -dependent NE transport that is DS-sensitive (26) . We have also shown the presence of an ϳ85-kDa immunoreactive NET protein band in trophoblast cultures as a major protein (26) by Western blot analyses. We now directly identified NET protein expression by immunostaining with a primary antibody raised against the rNET (amino acids 535-557) (Fig. 1B) . NET immunostaining was blocked by preincubation with the peptide against which the antibody was raised (Fig. 1C) , indicating the presence of NET in native cells.
PKC-mediated Down-regulation of Placental NET-Treatment of trophoblasts with the PKC activator ␤-PMA decreased NE uptake in a dose-and time-dependent manner. The concentration (0.5 M) and time (30 min) of ␤-PMA treatment were chosen after testing the dose (0.01-1.0 M) and time dependence (5-60 min) of the effect of ␤-PMA on NE uptake. Treatment with ␤-PMA (10 nM) for 30 min significantly (12%) inhibited NE uptake (data not shown). A significant (17%) inhibition was also observed after 5 min of treatment time with 0.5 M ␤-PMA (data not shown). A maximum inhibition (ϳ30%) of NE FIG. 2. PKC activation decreases NE uptake capacity. A, PMA specificity. Trophoblasts treated with the PKC activator, ␤-PMA (0.5 M), or ␣-PMA (0.5 M), the inactive isomer of ␤-PMA, or staurosporine (1 M) alone or pretreated with 1 M staurosporine for 20 min before ␤-PMA treatment for 30 min and NE uptake assays were performed as described under "Experimental Procedures." B, kinetic analysis. Kinetic experiments for NE uptake were performed as described under "Experimental Procedures." To define specific NE transport via NETs, parallel uptake assays were carried out in the presence of 1 M DS. ␤-PMA treatment decreased the maximal velocity (V max ) by ϳ30% with little or no change in affinity (K m ) of the transporter for NE. Data derived from three separate experiments, each in triplicate, are given as mean Ϯ S.E. (*, p Ͻ 0.05). Inset, Eadie-Hofstee plot.
FIG. 1.
NET expression in rat placental trophoblast cultures. Photographs of NET immunoreactivity in rat placental trophoblasts. Polyclonal NET antibody raised against a rat NET sequence was used to immunostain the trophoblasts as described under "Experimental Procedures." A, live cell image of trophoblasts in culture shows single nucleated cytotrophoblasts and differentiated multinucleated trophoblasts. B, immunostaining of trophoblasts with rNET antibody (amino acids 535-557) reveals specific NET expression. C, peptide antigen that was used to raise the NET antibody completely blocks NET immunostaining.
uptake was observed after a 30-min incubation time with 0.5 M ␤-PMA (Fig. 2A) . The inactive isomer ␣-PMA (0.5 M) had no effect on NE uptake (Fig. 2A) . In addition, staurosporine, the broad spectrum kinase inhibitor, completely blocked the inhibitory effect of ␤-PMA ( Fig. 2A) , suggesting that the activation of PKC is involved in ␤-PMA-induced decrease in NE uptake by trophoblasts. Kinetic analysis indicated that ␤-PMA treatment decreased the maximal velocity (V max ) by ϳ30% (from 328.8 Ϯ 19.13 to 240.7 Ϯ 8.83 pmol/10 6 cells/10 min) with little or no change in affinity of the transporter for NE (Fig.   2B ). (K m values: control 2.5 Ϯ 0.3 M; ␤-PMA 2.6 Ϯ 0.2 M). The inset in Fig. 2B shows the linear fitting of the uptake data, which is consistent with a single population of NE uptake sites.
PKC-mediated NET Sequestration from the Cell Surface-In order to examine whether the decrease in V max is due to a change in surface NET density, nisoxetine binding experiments with whole cell trophoblasts were performed at 4°C. 3 H] nisoxetine was defined by using 10 M DS. Data from three separate experiments performed in triplicate are given as mean Ϯ S.E. C, Biotinylation. Trophoblasts were treated with ␤-PMA or vehicle before biotinylation with sulfo-NHS-biotin as described under "Experimental Procedures." Aliquots (40 l) of total and entire eluate (50 l) from avidin beads were loaded onto gels, and the blot was probed with an affinity-purified NET-specific antibody. A representative blot indicates two species of NET-specific bands at ϳ85 kDa, and one species at ϳ48 kDa are identified in the trophoblasts. Stau, staurosporine. D, proteins from avidin-unbound fractions were trichloroacetic acid-precipitated, and equal amount proteins were subjected to SDS-PAGE followed by immunoblotting with NET-specific antibody. A representative blot shows NET protein levels in intracellular pools. E, biotinylation of NETs was quantified using NIH image, and the densities of ϳ85-kDa band from three separate experiments are presented as mean Ϯ S.E. (Fig. 3A) . In order to test whether the ␤-PMA-mediated decrease in cell surface NET density was due to sequestration, nisoxetine binding was performed with membranes prepared from cell extracts. Under these conditions, there was no change in either (Fig. 3B) .
Although nisoxetine is used as a ligand for quantifying NETbinding sites, it may not accurately define surface NET-binding sites. Therefore, biotinylation experiments were used to assess changes in surface NET following ␤-PMA treatment. As shown in Fig. 3C , there was a significant decrease in the amount of immunoreactive NET proteins that were surface-biotinylated following ␤-PMA treatment. ␤-PMA decreased NET immunoreactivity to 70 Ϯ 5% of control value in the biotinylated or cell surface fraction and significantly increased the amount of nonbiotinylated intracellular transporter (Fig. 3D) . There was no change in the total NET protein expression as measured by immunoblotting (Fig. 3C) . Staurosporine (1 M) completely blocked the ␤-PMA-mediated reduction in biotinylated NET (Fig. 3C) . Quantified band densities were presented in Fig. 3E . ␤-PMA had no effect on the total amount of calnexin, and no calnexin was present in avidin-bound fractions (Fig. 3C, lower  panel) , suggesting that the cells were intact, and intracellular proteins were not inappropriately biotinylated.
Calcium-independent Down-regulation of NET-␤-PMA (0.5 M) produced ϳ30% inhibition of NE uptake in the presence of Ca 2ϩ (regular Ca 2ϩ containing KRH buffer) (Fig. 4A) . In trophoblasts, calcium depletion by BAPTA-AM or EGTA has been used to block the regulation of 15-hydroxyprostaglandin dehydrogenase by corticotrophin-releasing hormone (40) . In contrast, the ␤-PMA-mediated inhibition of NE uptake was observed even after 2 h of treatment of cells with 10 M BAPTA-AM in Ca 2ϩ -free KRH buffer to deplete intracellular calcium stores (Fig. 4A) . Surface biotinylation experiments confirmed that removal of Ca 2ϩ did not prevent ␤-PMA-induced NET sequestration (Fig. 4B) .
PKC-mediated Stimulation of NET Internalization (Endocytosis)-PKC activation in trophoblasts results in decreased NE
transport, decreased V max , and decreased cell surface NET density (Figs. 2 and 3) . NET internalization was examined by using reversible biotinylation strategies and by quantifying the fraction of surface NET that moves in a time-dependent manner to an intracellular compartment. Biotin from biotinylated proteins remaining on the surface at the end of a particular treatment protocol was removed by treatment with MesNa, a nonpermeant reducing agent that cleaves disulfide bond and liberates biotin from biotinylated proteins at the cell surface. The amount of biotinylated proteins resistant (inaccessible) to MesNa treatment or reversal of biotinylation is defined as "the amount of protein endocytosed or internalized." Incubation of the cells at 37°C in the absence or presence of ␤-PMA before MesNa reversal of surface biotinylation permitted evaluation of NET internalization occurring in the absence of ␤-PMA (basal endocytosis) versus ␤-PMA-mediated changes in NET internalization (␤-PMA stimulated endocytosis). Lane 1 in Fig.  5A shows the amount of total NET that is biotinylated (no MesNa treatment). MesNa treatment immediately after biotinylation of trophoblasts showed no biotinylated NET (lane 2, Fig. 5A ) indicating the absence of internalization at 4°C. A small but significant increase in biotinylated NET was seen from trophoblasts exposed to ␤-PMA at 37°C for 5 min when compared with vehicle treatment (lanes 3 and 4, Fig. 5) . A significant increase in the amount of biotinylated (internalized) NET from trophoblasts treated with ␤-PMA at 37°C for 30 min was observed when compared with vehicle-treated trophoblasts ( lanes 5 and 6, Fig. 5A ). The percent internalization is shown in Fig. 5B that correlated well with time-dependent inhibition (10% by 5 min and 30% by 30 min) of NE uptake by ␤-PMA.
Clathrin/Dynamin-and Caveolae-independent but Lipid Raft-mediated NET Internalization-The observation that ␤-PMA reduced NET present on the cell surface suggests that endocytic pathways are involved. To test this hypothesis, multiple approaches were used. Inhibition of clathrin-mediated endocytosis by ConA (0.25 mg/ml) or MDC (50 M) did not prevent the NET down-regulation by ␤-PMA (Fig. 6, A and B) . Depletion of K ϩ or treatment with hypertonic sucrose (0.45 M) reduced NE transport but failed to block the ␤-PMA-induced inhibition of NE uptake (data not shown). Incubation with cycloheximide (30 g/ml) for 30 min prior to and during ␤-PMA treatment did not impair the down-regulation of cell surface NET induced by PKC activation, thereby ruling out the contribution of new NET protein synthesis (data not shown). Expression of dominant negative mutants of dynamin 1 or dynamin 2
FIG. 4. ␤-PMA-mediated NET downregulation is calcium-independent.
Trophoblasts were treated with 10 M membrane-permeable Ca 2ϩ -chelator BAPTA-AM in calcium-free KRH buffer for 2 h followed by incubation in the presence or absence of 0.5 M ␤-PMA for 30 min, and NE uptake assays and biotinylation experiments were performed as described under "Experimental Procedures." A, uptake data are presented as mean Ϯ S.E. of three experiments carried out in triplicate. B, a representative blot from biotinylation experiments shows no significant change in ␤-PMA-induced loss of NET surface density by calcium removal. Biotinylated NETs (85 kDa) were quantified using NIH image, and band densities from three separate experiments are shown in the lower panel as the mean Ϯ S.E. Values from ␤-PMA treatments were compared with vehicle treatments using Student's t test (*, p Ͻ 0.05). also failed to block the PKC-mediated NET down-regulation and internalization (Table I) . However, expression of K44A dynamin 1 completely blocked the ␤-PMA-mediated TfR internalization (Fig. 7, A and B) . In addition, ␤-PMA-mediated inhibition of taurine uptake was completely blocked by ConA treatment and K ϩ depletion (Fig. 8A ) that are known to inhibit clathrin-mediated endocytosis. Taken together, these results confirmed that PKC-mediated NET internalization is not mediated by the dynamin-dependent, clathrin-mediated endocytic pathway.
The cholesterol-disrupting agents do not interact with cholesterol in coated pits (41) and are therefore ideal for distinguishing pathways mediated by clathrin-coated pits or caveolae/lipid rafts. Because we found abundant expression of caveolin protein in the trophoblasts, we tested the ability of filipin and nystatin, inhibitors of caveolae/lipid raft-mediated endocytosis as well as expression of dominant negative mutants of caveolin 1 or that of caveolin 3, to block the ␤-PMA effects on NET. The expression of dominant negative mutants of caveolin 1 or caveolin 3 failed to block PKC-mediated NET down-regulation (Table I) . However, there was a significant reduction in the amount of caveolin-dependent CTXB internalization as observed by a direct dot blot analysis (Fig. 7, C and  D) . This suggests that the caveolin mutants were effective in blocking caveolae-mediated endocytosis. Treatment of cells with the cholesterol-disrupting agent filipin (5 g/ml) completely blocked the ␤-PMA-mediated effects on NET (Fig. 6, A  and B) . Treatment with nystatin also blocked the ␤-PMA-mediated inhibition of NE uptake (data not shown). However, under similar conditions, filipin did not affect the ␤-PMAmediated inhibition of taurine uptake (Fig. 8A) suggesting that the effect of filipin is specific to NET regulation. In addition, there was no change in the ␤-PMA-mediated translocation of PKC␣ or PKC⑀ from the cytosol to the plasma membrane following filipin treatment (Fig. 8B) suggesting that the filipinmediated blockade of NET down-regulation was not due to altered PKC signaling pathways. These results collectively demonstrate that lipid rafts but not caveolae are involved in the ␤-PMA-induced NET sequestration.
To examine the role of lipid rafts in the ␤-PMA-mediated effects, discontinuous sucrose gradient centrifugation was used to measure the amount of NET and other marker proteins in the isolated fractions (lipid rafts and nonlipid rafts). Immunoblot analyses of the proteins in the isolated fractions revealed that NET proteins are present in lipid raft fractions (fractions 4 and 5) (Fig. 9A) . Markers for lipid rafts such as GM1 and 5 and 6) . B, biotinylated NET (85 kDa) bands were quantified using NIH image, and the percentage internalized (compared with total surface NET) in three separate experiments are shown as the mean Ϯ S.E. Values from ␤-PMA treatments were compared with vehicle treatments using Student's t test (*, p Ͻ 0.05).
FIG. 6.
Chemical agents that block caveolae/lipid raft-mediated endocytosis but not the clathrin-mediated pathway block the ␤-PMA-induced loss of cell surface NET. Trophoblasts were treated with vehicle or ␤-PMA following treatments with chemical agents, and NE uptake assays and biotinylation experiments were carried out as described under "Experimental Procedures." A, uptake data are presented as mean Ϯ S.E. of three experiments carried out in triplicate. B, representative blot of three separate biotinylation experiments shows no significant change in ␤-PMA-induced loss of NET surface density by treatments with ConA or MDC that prevent clathrinmediated endocytosis but a significant inhibition by filipin that blocks caveolae/lipid raft-mediated endocytosis. Lower panel represents quantitative values of mean band (ϳ85 kDa) densities obtained from three measurements. Asterisks indicate significant block of ␤-PMA-mediated inhibition of NE uptake and loss of NET protein from the cell surface by filipin compared with the control (Student's t test; *, p Ͻ 0.05).
caveolin were also detected in these fractions (Fig. 9) . Treatment of trophoblasts with ␤-PMA decreased the levels of NET in the lipid raft fractions, with concomitant increases of NET protein in the nonlipid raft fractions (fractions 7-9) (Fig. 9) . These results provided further evidence for the involvement of lipid rafts in the PKC-mediated NET internalization.
PKC-mediated NET Phosphorylation-Activation of PKC and inhibition of phosphatases regulate both transport function and phosphorylation of DAT and SERT (39, 42) . Similar to the effects observed after ␤-PMA treatment, okadaic acid, an inhibitor of protein phosphatases PP1/2A, also inhibited NE uptake (Fig. 10A) . Whether NET exists in phosphorylated form and/or whether modulation of PKC or protein phosphatases regulate phosphorylation of NET remains unexplored. To identify phosphorylated NET, SDS-PAGE/autoradiography of immunoprecipitates from metabolically labeled trophoblasts was performed. As shown in Fig. 10B , a broad phosphoprotein band centered at ϳ85 kDa was observed in vehicle or ␤-PMA or okadaic acid-treated cells when immunoprecipitations were performed using NET antiserum. In vehicle-treated cells, we found a less intense band indicating basal level of phosphorylation. Treatment of metabolically labeled trophoblasts with ␤-PMA or okadaic acid resulted in 2-3-fold increase in the phosphorylation of 85-kDa protein (Fig. 10B) . This phosphoprotein band was not visible from the immunoprecipitates if preimmune serum or NET antiserum preblocked with antigenic peptide or irrelevant IgG or protein A-Sepharose alone was utilized for immunoprecipitations (control experiments) (Fig.  10B) . The NET immunoisolated from the trophoblasts migrates at ϳ85 kDa (as a doublet) and ϳ48 kDa in immunoblots. We observed similar size of 32 P-labeled bands under lower exposure. The 48-kDa band showed very less 32 P incorporation and could be visualized only after longer exposure. These findings support the contention that the phosphorylated ϳ85-kDa (dou- FIG. 7 . Dominant negative mutants of dynamin and caveolin effectively block clathrin-and caveolae-mediated endocytosis, respectively. A, TfR internalization. Trophoblasts were transfected with K44A dynamin 1 or the vector, and the transfected cells were treated with vehicle or ␤-PMA as described under "Experimental Procedures." Biotinylation followed by immunoblotting with anti-TfR antibody was carried out as described under "Experimental Procedures." A representative blot from three separate biotinylation experiments is shown. B, bar graph. Biotinylation was quantified using NIH image, and the densities of TfR band from three separate experiments are presented as mean Ϯ S.E. Asterisks indicate a significant reduction in surface TfR level following ␤-PMA treatment in vector-transfected cells and a significant block of ␤-PMA-induced TfR sequestration in K44A dynamin (K44A-dyn) 1 transfected trophoblasts compared with vector control (Student's t test; *, p Ͻ 0.05). C, CTXB internalization. Trophoblasts were transfected with S80E caveolin 1 or DGV caveolin 3 or the vector as described under "Experimental Procedures." Transfected cells were incubated with peroxidase-conjugated CTXB, and the internalization of CTXB was measured as described under "Experimental Procedures." A representative blot from three separate dot blot experiments is shown. D, bar graph. Dot densities of internalized (intracellular) CTXB were quantified by NIH image, and mean values from three separate experiments are presented as mean Ϯ S.E. Asterisks indicate significant block of CTXB internalization by S80E caveolin 1 (cav 1) and DGV caveolin 3 (cav 3) mutants compared with vector control (Student's t test; *, p Ͻ 0.05).
TABLE I Effect of dynamin and caveolin mutant expressions on PKC-mediated
NET down-regulation K44A mutants of dynamin1 and 2, S80E mutant of caveolin 1, and DGV mutant of caveolin 3 were expressed as described under "Experimental Procedures." NET function by NE uptake measurements and NET surface distribution by biotinylation were performed 48 h posttransfection. Experiments were conducted in triplicate, and the mean values Ϯ S.E. from three separate experiments are given. ABDU indicates arbitrary band density units. blet) and ϳ48-kDa proteins that were immunoprecipitated by NET-specific antiserum from trophoblast extracts represent phosphorylated NET protein.
DISCUSSION
Although several reports indicate that internalization plays an important role in the regulation of transporter function (13, 14, 43) , the mechanisms underlying these regulatory events are known for DAT and GAT1 only (20, 44) . DATs are internalized via a dynamin-dependent, clathrin-mediated pathway and are sorted to recycling or degradative pathways (18, 19, 45) . The ␥-aminobutyric acid transporter GAT1 is also internalized via a clathrin-and dynamin-dependent pathway and is subjected to regulated recycling (20) . It is not yet known whether the NE transporter trafficking is regulated in a similar fashion. In this study, we demonstrate in placental trophoblasts that down-regulation of NET following treatment with a PKC activator involves enhanced internalization (endocytosis) of the transporter protein and that the effects of ␤-PMA are Ca 2ϩ -independent. This process appears to involve a lipid raftmediated internalization and is independent of clathrin-and/or caveolae-mediated processes. NET proteins in trophoblasts are localized to the plasma membrane as observed by immunostaining, and ␤-PMA produces a rapid reduction in the maximal capacity (V max ) of NE transport without altering the K m . Biochemical (13, 14) , radioligand binding (12) , and immunological (13) studies indicate that monoamine transporters undergo rapid surface redistribution in response to regulatory stimuli, which in many cases involve PKC activation. Consistent with these previous reports, we observed that activation of PKC reduces nisoxetine-binding sites present on the surface of the trophoblasts, suggesting that PKC activity dictates cell surface NET density. This reduction in cell surface nisoxetine-binding sites was further confirmed by the biotinylation data.
PKC plays a pivotal role in a transmembrane signal transduction chain found ubiquitously in mammalian cells. At least 12 isoforms of PKC have been identified to date. These are classified as the classical or conventional PKCs (isoforms ␣, ␤1, ␤2, and ␥) that require phosphatidylserine, diacylglycerol, and Ca 2ϩ for activation; the novel PKCs (isoforms ␦, ⑀, , , and ) that require phosphatidylserine and diacylglycerol only; and the atypical PKCs (isoforms , , and ) that require neither diacylglycerol nor Ca 2ϩ (46) . Placental tissue expresses several isoforms of PKC that include ␣, ␤, ␥, ⑀, , and , and PKC-mediated phosphorylation has been implicated in the regulation of cytoskeletal elements (47) and amino acid transporters (48) in placenta. Phorbol esters and other tumor promoters mimic natural activators of both conventional PKCs and novel PKCs but do not activate atypical PKCs (49) . Fresh or cultured placental trophoblasts in particular express ␣, ⑀, and isoforms of PKC, and following treatment with ␤-PMA, only ␣ and ⑀ isoforms but not isoform translocate from the cytosol to the plasma membrane (33) . This suggests that the ␤-PMA-mediated inhibition of NE uptake in trophoblasts occurs following activation of either conventional PKCs or novel PKCs. However, complete removal of calcium (both external and internal) did not block the effect of ␤-PMA suggesting that Ca 2ϩ -independent novel PKC isoforms might be involved in the regulation of placental NET. Under similar conditions of calcium removal, the ␤-PMA-induced inhibition of paroxetine-sensitive [ 3 H]5HT uptake by trophoblasts was completely blocked. 2 These results indicate the specific involvement of Ca 2ϩ -independent PKC isoforms in the regulation of NET in the trophoblast. In SK-N-SH cells, PKC-linked muscarinic acetylcholine receptors regulate NET activity in a calciumindependent manner (12) . In contrast, the phosphatidylinositol 3-kinase-linked and insulin-mediated regulation of NET is calcium-dependent (29) .
The decrease in cell surface NET density observed following ␤-PMA treatment in the present study could be due to either enhanced internalization or reduced recycling. The data from reversible biotinylation experiments support the hypothesis that decreased cell surface NET protein after ␤-PMA treatment occurs via enhanced internalization of the transporter. ␤-PMAinduced NET down-regulation did not involve dynamin, and clathrin-mediated internalization as K ϩ depletion or hypertonic sucrose or treatment with ConA and MDC were ineffective. In addition, expression of dominant negative mutants of dynamin 1 and dynamin 2 in trophoblasts also had no effect on ␤-PMA-mediated NET down-regulation. However, the effective block of ␤-PMA-mediated inhibition of taurine transport by ConA treatment or K ϩ depletion suggests that these manipulations to inhibit clathrin-mediated endocytosis were effective on another transporter protein of the same gene family. In addition, expression of dominant negative dynamin mutant effectively blocked TfR internalization suggesting that K44A dynamin was also effective in inhibiting clathrin-mediated endocytosis. It is well known that TfR internalizes via clathrinmediated endocytosis, and dominant negative dynamin mutants effectively block TfR internalization (50) . Earlier, it has also been shown that PKC activation accelerates TfR internal- ization (51) . Coexpression of human NET and K44A mutant of dynamin 1 in HEK-293 cells completely blocked the effect of ␤-PMA on NE transport as well as NET sequestration (Table I ), suggesting that the mechanisms underlying PKC-induced internalization are cell type-specific. The expression of K44A dynamin 1 and dynamin 2 mutants was confirmed by immunoblotting with anti-HA and anti-GFP antibodies. Trophoblasts as well as HEK-293 cells expressed similar levels of endogenous dynamin proteins (based on immunoreactivity to anti-dynamin antibodies) and also transfected dominant negative mutant dynamin proteins (based on immunoreactivity to anti-HA and anti-GFP antibodies) ruling out the possibility of discrepancy of expression efficiencies between cell types (data not shown). These results collectively demonstrate that the PKC-mediated NET sequestration in trophoblasts occurs by dynamin-independent endocytic mechanisms. Although many GPCRs are internalized via clathrin-dependent mechanisms, M2 muscarinic acetylcholine receptors are internalized by clathrin-independent mechanisms (50) .
Although treatments that disrupt dynamin and clathrin-dependent pathways were without effect, exposure of cells to filipin blocked the PKC-mediated NET down-regulation in trophoblasts. Under similar conditions of filipin treatment, the ␤-PMA-induced inhibition of taurine uptake was unaltered suggesting that the filipin effect is specific to NET down-regulation. In addition, phorbol ester-induced translocation of PKC␣ or PKC⑀ from the cytosol to the plasma membrane remained intact following filipin treatment. Together, these results ruled out the possibility that filipin, being a cholesteroldepleting agent, can block ␤-PMA-mediated NET internalization by altering the membrane integrity and hence altering the PKC signaling. Surprisingly, neither the dominant negative S80E mutant of caveolin 1 nor the DGV mutant of caveolin 3 blocked the ␤-PMA effects on NET when transfected into trophoblasts. However, the inhibition of CTXB internalization by caveolin mutants indicates that these mutants were effective in inhibiting the caveolae-mediated endocytosis. CTXB by binding to the cell surface ganglioside GM1 internalizes via caveolae, and S80E caveolin 1 mutant has been shown to block CTXB uptake by adipocytes (36) . Expression of mutant proteins of caveolin 1 and caveolin 3 was confirmed by immunoblotting with anti-Myc and anti-HA antibodies, respectively.
The presence of NET in lipid rafts and the reduction of NET levels following PKC activation (Fig. 9 ) strongly suggest that FIG. 9 . Lipid rafts contain NET proteins and ␤-PMA redistributes lipid raft-associated NET. Trophoblasts were treated with vehicle (A), and 0.5 M ␤-PMA (B) for 30 min at 37°C. Treated cells were solubilized in MBS containing 1% Triton X-100 and subjected sucrose gradient centrifugation as described under "Experimental Procedures." 10 fractions of 1 ml were collected along with the pelletted material (P). Fractions 1-10 are from top to bottom. Trichloroacetic acid-precipitated proteins from these fractions were analyzed by 4 -15% linear gradient SDS-PAGE and Western blotting for the distribution of different proteins using indicated antibodies. Aliquots from total homogenate (T) and resuspended pellet (P) were also loaded on the gels. Sucrose concentrations are shown at the bottom. Representative Western blots of three separate experiments corresponding to each protein are shown.
FIG. 10. ␤-PMA-induced NET phosphorylation.
A, trophoblasts were treated with ␤-PMA (0.5 M), okadaic acid (10 nM), or the vehicle for 30 min, and NE uptake assays were performed as described under "Experimental Procedures." Values of percent inhibition of NE uptake are presented as mean Ϯ S.E. of three separate experiments carried out in triplicate. Values from ␤-PMA-or okadaic acid-treated cells were compared with respective vehicle-treated cells using Student's t test (*, p Ͻ 0.05). B, metabolically labeled trophoblasts were treated with vehicle, ␤-PMA (0.5 M), or okadaic acid (10 nM) for 30 min and subjected to immunoprecipitations with NET antiserum, preimmune serum (Preimm), or NET antiserum preabsorbed (Pre-absorb) by the antigen column or protein A-Sepharose (Prot. A Seph.) or an irrelevant (Irrel) antibody (anti-calnexin) followed by autoradiography as described under "Experimental Procedures." Phosphorylated protein bands corresponding to NET protein are shown. C, the fold increase in NET phosphorylation is shown in arbitrary units. The intensity of phosphorylated band is increased ϳ3-fold by ␤-PMA or okadaic acid treatments.
NET internalization in the trophoblast occurs via lipid rafts. The signals and the spatial regulation of signaling in lipid rafts are distinctly different from that of caveolae (22, 52, 53) , and therefore, signaling machinery specific to lipid rafts may be linked to PKC-mediated NET down-regulation. Recently, lipid raft-mediated internalization has been demonstrated for glucose transporter (GLUT4) (54, 55) . GLUT4 is similar to NET and DAT with respect to regulation by phosphatidylinositol 3-kinase-and insulin-mediated regulation (29, 56) . Membrane cholesterol modulates SERT activity in HEK-293 cells (57) . However, cholesterol appears to be involved in stabilizing transporter proteins but not in trafficking regulation. Thus, this is the first report in the Na ϩ /Cl Ϫ -dependent transporter family that is to identify lipid raft-mediated internalization as a mechanism underlying native NET regulation by PKC in the trophoblast.
Although the present findings show that native NET undergoes phosphorylation in response to PKC activation or PP1/2A inhibition, it is not known whether phosphorylation of NET leads to its internalization. DAT and SERT undergo phosphorylation (42, 39) , and SERT substrates modulate the degree of phosphorylation (58) . DAT is phosphorylated on N-terminal serine residues in rat striatum (59) , and N-terminal truncation of DAT abolishes PKC-mediated phosphorylation without impairing its internalization in HEK-293 cells (60) . However, in Chinese hamster ovary cells, N-terminal phospho-sites are required for the regulation of DAT function and phosphorylation by several kinases (61) . NET contains multiple consensus sites for several kinases, including PKC, that are distinct from those present in DAT or SERT. It is therefore possible that NET is regulated by mechanisms that are different for those of DAT and SERT. Whereas native systems that endogenously express transporters are great assets to identify the endogenous stimuli controlling the transporter function, heterologous expression systems are useful for asking mechanistic questions with regard to understanding the relationships among transporter trafficking, phosphorylation, and regulation. Current studies are aimed at understanding these complex relationships using phospho-site mutants of NET and should provide insights into our understanding of NET regulation.
Protein phosphatases also regulate the function and phosphorylation state of the NET in trophoblasts (Fig. 10) . In addition, in recent studies we have isolated native NET as a complex with PP2Ac, and we observed that the associated PP2A dephosphorylates phospho-NET. 3 The fact that monoamine transporters interact with PP2A (16) suggests a role for protein phosphatases in monoamine transporter phosphoregulation. Recently, Uhl et al. (62) reported that KEPI and GBPI, members of a family of PKC-dependent inhibitors of PP1 and PP2A, alter DAT activity. It is possible that phorbol esters could alter PKC-mediated effects on proteins such as KEPI, and may provide alternative pathways for PKC-mediated transporter regulation.
Lipid rafts are residents of a number of signaling molecules (22) that may have appropriate regulatory machinery for PKCmediated NET regulation. It is tempting to speculate that a part of NET protein exists as a readily available pool in cholesterol-rich lipid rafts that are available for regulation by PKC. In addition, lipid rafts may operate as an obligatory transition station before transporter internalization. NETs may be regulated by different mechanisms in neuronal versus non-neuronal tissues depending upon the needs and functional significance of that particular organ. As placenta is an example of a non-innervated tissue, placental control of amine transport via lipid raft-mediated NET regulation may be one of the underlying mechanisms by which placenta regulates physiologic catecholamine levels. Future studies examining the signals and molecules linked to this regulatory machinery may provide insight into the participation of NET in the placental control of NE levels.
